Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
SAI Life Sciences Ltd. ( (IN:SAILIFE) ) has shared an announcement.
Sai Life Sciences Ltd. has announced a significant capacity addition by acquiring a 1.21-acre land parcel in Shamirpet, Hyderabad, with an investment of approximately Rs. 15 crore from internal accruals. This investment will be used to establish an R&D facility that will enhance the existing Unit II Hyderabad Facility, with partial operations expected to commence by Q4 of the fiscal year ending March 2026, which is likely to bolster the company’s R&D capabilities and market position.
More about SAI Life Sciences Ltd.
Sai Life Sciences Ltd. operates in the pharmaceutical sector, focusing on drug discovery, development, and manufacturing services. The company is dedicated to augmenting its R&D capabilities and strengthening its presence in the pharmaceutical market.
YTD Price Performance: -11.07%
Average Trading Volume: 339,609
For an in-depth examination of SAILIFE stock, go to TipRanks’ Stock Analysis page.